Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis: A Randomized Trial

Volume: 146, Issue: 9, Pages: 621 - 630
Published: May 1, 2007
Abstract
Background null Tumor necrosis factor-alpha is present in arteries in giant cell arteritis. null Objective null To evaluate the efficacy of infliximab, an anti-tumor necrosis factor-alpha agent, in giant cell arteritis. null Design null Randomized, controlled trial. null Setting null 22 sites in the United States, the United Kingdom, Belgium, Italy, and Spain. null Patients null 44 patients with newly diagnosed giant cell arteritis that was in...
Paper Details
Title
Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis: A Randomized Trial
Published Date
May 1, 2007
Volume
146
Issue
9
Pages
621 - 630
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.